Clinical Trials List
2023-11-01 - 2025-12-31
Phase II
Not yet recruiting3
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Hsu-ching Huang 無
- Chia-I Shen 無
- Ming-Huang Chen 無
- 蕭慈慧 無
- Yi-Ping Hung 無
- Yuh-Min Chen 無
- 趙恒勝 無
- Yung-Hung Luo 無
- YEN-HAN TSENG 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Shang-Yin Wu 無
- 郭鈞偉 無
- Chun-Hui Lee 無
- 蔡政軒 無
- Seu-Chun Yang 無
- Wu-Chou Su 無
- Chian-Wei Chen 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 吳教恩 無
- 林定佑 無
- 邱立忠 無
- 張境夫 無
- 柯皓文 無
- Chih-Hung Chen 無
- Ping-Chih Hsu 無
- Cheng-Ta Yang 無
- 黃宗楨 無
- Chien-Ying Liu 無
- 枋岳甫 無
- Chih-Liang Wang 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
120 participants
